This antibody targets a probable lyase enzyme crucial for C-terminal α-amidation of peptides. The enzyme facilitates the dismutation of the unstable peptidyl-(2-hydroxyglycine) intermediate, yielding glyoxylate and the corresponding desglycine peptide amide. C-terminal amidation is essential for the full biological activity of many peptides, including neuropeptides.